| The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis M Javadian, T Gharibi, N Shekari, M Abdollahpour‐Alitappeh, ... Journal of Cellular Physiology 234 (5), 5399-5412, 2019 | 57 | 2019 |
| Parasite-derived microRNAs in plasma as novel promising biomarkers for the early detection of hydatid cyst infection and post-surgery follow-up Z Alizadeh, M Mahami-Oskouei, A Spotin, T Kazemi, E Ahmadpour, P Cai, ... Acta tropica 202, 105255, 2020 | 50 | 2020 |
| Circulating MicroRNAs: valuable biomarkers for the diagnosis and prognosis of gastric cancer N Shekari, B Baradaran, D Shanehbandi, T Kazemi Current medicinal chemistry 25 (6), 698-714, 2018 | 39 | 2018 |
| Critical microRNAs in lung cancer: recent advances and potential applications H Zarredar, K Ansarin, B Baradaran, N Shekari, S Eyvazi, F Safari, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2018 | 36 | 2018 |
| Docosahexaenoic acid suppresses migration of triple‐negative breast cancer cell through targeting metastasis‐related genes and microRNA under normoxic and hypoxic conditions M Javadian, N Shekari, MS Soltani‐Zangbar, A Mohammadi, B Mansoori, ... Journal of cellular biochemistry 121 (3), 2416-2427, 2020 | 21 | 2020 |
| Let-7a could serve as a biomarker for chemo-responsiveness to docetaxel in gastric cancer N Shekari, F Asghari, N Haghnavaz, D Shanehbandi, V Khaze, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2019 | 21 | 2019 |
| Regulatory interplay between microRNAs and WNT pathway in glioma P Tabnak, A Mafakheri, ZH Emsailpoor, T Kazemi, N Shekari Biomedicine & Pharmacotherapy 143, 112187, 2021 | 18 | 2021 |
| Synergistic Beneficial Effect of Docosahexaenoic Acid (DHA) and Docetaxel on the Expression Level of Matrix Metalloproteinase-2 (MMP-2) and MicroRNA-106b in … N Shekari, M Javadian, M Ghasemi, B Baradaran, M Darabi, T Kazemi Journal of Gastrointestinal Cancer 51, 70-75, 2020 | 13 | 2020 |
| Susceptibility to ERAP1 gene single nucleotide polymorphism modulates the inflammatory cytokine setting in ankylosing spondylitis M Hemmatzadeh, F Babaie, F Ezzatifar, FS Mohammadi, M Ebrazeh, ... International journal of rheumatic diseases 22 (4), 715-724, 2019 | 13 | 2019 |
| DHA abolishes the detrimental effect of docetaxel on downregulation of the MICA via decreasing the expression level of MicroRNA-20a in gastric cancer N Shekari, M Javadian, S Ghaffari, B Baradaran, M Darabi, T Kazemi Journal of Gastrointestinal Cancer 51, 545-551, 2020 | 11 | 2020 |
| Combination therapy with KRAS and P38α siRNA suppresses colorectal cancer growth and development in SW480 cell line S Kamran, E Seyedrezazadeh, D Shanehbandi, M Asadi, V Zafari, ... Journal of Gastrointestinal Cancer, 1-8, 2021 | 8 | 2021 |
| Docosahexaenoic acid (DHA) and linoleic acid (LA) modulate the expression of breast cancer involved miRNAs in MDA-MB-231 cell line DEA Komi, N Shekari, P Soofian-Kordkandi, M Javadian, D Shanehbandi, ... Clinical Nutrition ESPEN 46, 477-483, 2021 | 7 | 2021 |
| microRNA-based biomarkers in lung cancer: recent advances and potential applications D Shanehbandi, M Asadi, E Seyedrezazadeh, V Zafari, N Shekari, ... Current Molecular Medicine 23 (7), 648-667, 2023 | 6 | 2023 |
| A scoping review on the significance of programmed death-ligand 1-inhibiting microRNAs in non-small cell lung treatment: A single-cell RNA sequencing-based study MA Shadbad, F Ghorbaninezhad, H Hassanian, NK Ahangar, ... Frontiers in Medicine 9, 1027758, 2022 | 5 | 2022 |
| Autophagy-regulating microRNAs: two-sided coin in the therapies of breast cancer. N Shekari, M Asadi, M Akbari, B Baradaran, H Zarredar, ... European Review for Medical & Pharmacological Sciences 26 (4), 2022 | 5 | 2022 |
| Paclitaxel May Inhibit Epithelial-Mesenchymal Transition Properties of Triple-negative Breast Cancer Cell Line via Altering the Expression of EMT-promoting and–inhibiting MicroRNAs N Haghnavaz, F Asghari, N Shekari, D Shanehbandi, M Javadian, ... Middle East Journal of Cancer 11 (1), 42-49, 2020 | 3 | 2020 |
| Docosahexaenoic acid (DHA) impairs docetaxel-induced up-regulation of miR-30a-5p and miR-126-5p tumor suppressors in gastric cancer cell line N Shekari, H Abbasi-Kenarsari, B Baradaran, T Kazemi Iranian Journal of Blood and Cancer 16 (1), 89-96, 2024 | | 2024 |
| Durvalumab and taxane family combination therapy enhances the antitumoral effects for NSCLC: An in vitro study MR Firoozi, S Sadeghi‐Mohammadi, M Asadi, N Shekari, F Seyed Nejad, ... Cell Biochemistry and Function 42 (1), e3919, 2024 | | 2024 |
| VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy N Shekari, D Shanehbandi, T Kazemi, H Zarredar, B Baradaran, SA Jalali Cancer Cell International 23 (1), 265, 2023 | | 2023 |
| Study of the Effect of Linoleic Acid on the Expression Level of MicroRNA-106b and MicroRNA-20a and their Related Target MHC Class I Chain-related Protein A in Docetaxel-treated … N Shekari, T Kazemi, M Moradi, E Eghbali, B Sepehri, V Khaze Shahgoli, ... Middle East Journal of Cancer 12 (3), 342-349, 2021 | | 2021 |
Tohid KazemiTabriz University of Medical SciencesVerified email at tbzmed.ac.ir
